Brain activity and hearing tests in Rett syndrome
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study measures brain waves and hearing in people with Rett syndrome to better understand how the condition affects the brain's ability to process sound. The information may help develop better treatments and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a confirmed diagnosis of classic Rett syndrome with a genetic test showing a MECP2 mutation
- Be at least 2 years old and past the early decline stage of the condition
- Have normal or corrected hearing (no hearing loss)
- Be able to tolerate a safe, non-invasive brain-wave recording (EEG) that takes about an hour
- Have a parent or caregiver who can provide permission and complete study forms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether an antioxidant “cocktail” helps children and teens with Rett syndrome compared with a placebo (inactive drink). If you join, you’ll get study assessments and blood tests to see if the treatment is safe and helpful.
This study measures brain and nerve activity (brain signals) to find patterns that match Rett syndrome. It may help researchers better track Rett changes over time and develop more precise ways to measure response in future treatments.
This registry collects health and family information about people with Rett syndrome (or specific changes in the MECP2 gene). It helps researchers understand the condition better and plan future studies. Participation may include sharing information for living individuals or those who have passed away.
This study tests an investigational drug called NTI164 in girls and young women with Rett syndrome. It looks at how safe the drug is and whether it helps with symptoms. The study lasts for a period of time, and participants will be monitored closely.
This trial is a registry that collects health and genetic information from people with Rett syndrome. It may help researchers better understand how MECP2 loss-of-function changes lead to symptoms and how to support patients.
This trial tests a gene-editing approach for Rett syndrome in children who have a confirmed MECP2 gene mutation. It may help by targeting specific “hotspot” genetic changes that cause the condition.
Hear when a new Rett Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.